Since December 2019, COVID-19 has spread across the world almost through 2.5 years. As
of 16 June 2022, the cumulative number of confirmed cases of COVID-19 worldwide has …

Background: Exact information about the efficacy of various medications proposed by
regulatory bodies in children with COVID-19 is limited due to the lack of controlled trials in …

Children are the future of the world, but their health and future are facing great uncertainty
because of the coronavirus disease 2019 (COVID-19) pandemic. In order to improve the …

Introduction Sufficient data pertaining to the impact of the Coronavirus disease 2019 (COVID-
19) on pediatric cancer patients is still lacking. The aim of this prospective study was to …

Dear Editor: In the recent article by Mendez-Echevarria et al.[1], they shared their experience
with 8 pediatric patients with COVID-19 treated with Remdesivir in a safe and effective …

Background: The clinical features of coronavirus disease 2019 (COVID-19) in children have
been changing because of the emergence and rapid spread of variants of concern (VOC) …

The recent pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) has resulted in unprecedented morbidity and mortality worldwide. The host cells use …

Remdesivir (RDV) is the mainstay antiviral therapy for moderate to severe COVID-19.
Although remdesivir was the first drug approved for COVID-19, information about its efficacy …

Objective To describe COVID-19 in children and the differences between the two waves.
Methods The electronic medical records of children younger than 16 y of age with laboratory …

The World Health Organization (WHO) first declared the severe acute respiratory syndrome
coronavirus-2 (SAR-CoV-2) a pandemic on 11 March 2020 [1]. Although children with …